Age
Item
patients, male or female, > 18 years of age,
boolean
C0001779 (UMLS CUI [1])
Percutaneous Coronary Intervention elective Scheduled | PCI Drug-Eluting Stent
Item
patients who are scheduled for an elective pci with a drug eluting stent
boolean
C1532338 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C1532338 (UMLS CUI [2,1])
C1322815 (UMLS CUI [2,2])
Follow-up visit Willing
Item
patients willing to return for all required follow up visits.
boolean
C0589121 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Residence Nearby Hospital | Working Nearby Hospital
Item
patients live/work within a 60 mile radius of the washington hospital center.
boolean
C0237096 (UMLS CUI [1,1])
C1706276 (UMLS CUI [1,2])
C0019994 (UMLS CUI [1,3])
C0043227 (UMLS CUI [2,1])
C1706276 (UMLS CUI [2,2])
C0019994 (UMLS CUI [2,3])
Myocardial Infarction
Item
patient has experienced an acute myocardial infarction within the preceding 48 hours of the subsequent angioplasty.
boolean
C0027051 (UMLS CUI [1])
Left main coronary artery disease Without Protection | Stenosis Percentage
Item
unprotected left main coronary disease with >50% stenosis;
boolean
C1299433 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C1545588 (UMLS CUI [1,3])
C1261287 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
Kidney Failure Requirement Dialysis
Item
patients with renal failure requiring dialysis;
boolean
C0035078 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0011946 (UMLS CUI [1,3])
Cardiac ejection fraction
Item
patients with a documented ejection fraction < 30 percent at the time of subsequent pci;
boolean
C0232174 (UMLS CUI [1])
Life Expectancy
Item
patient with a life expectancy less than 12 months or malignancy.
boolean
C0023671 (UMLS CUI [1])
Aspirin allergy | Hypersensitivity Clopidogrel bisulfate | Hypersensitivity Plavix | Allergy prophylaxis Unsuccessful
Item
known allergies to aspirin or clopidogrel bisulfate (plavixr) and that cannot be medically managed;
boolean
C0004058 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0772326 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0633084 (UMLS CUI [3,2])
C1737226 (UMLS CUI [4,1])
C1272705 (UMLS CUI [4,2])
Operative Surgical Procedures Planned | Clopidogrel To be stopped | Indication Clopidogrel To be stopped
Item
planned surgery or other indication for requiring the cessation of clopidogrel within 12 months of pci;
boolean
C0543467 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C3146298 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C1272691 (UMLS CUI [3,3])
Medical condition Interferes with Study Subject Participation Status
Item
any significant medical condition which in the investigator's opinion may interfere with the patient's optimal participation in the study.
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
Bleeding tendency
Item
patients with known history of bleeding diathesis;
boolean
C1458140 (UMLS CUI [1])
Prothrombin time increased | Coumadin
Item
prothrombin time >1.5 times control; coumadin therapy
boolean
C0151872 (UMLS CUI [1])
C0699129 (UMLS CUI [2])
Platelet Count measurement
Item
platelet count <100 000/mm3;
boolean
C0032181 (UMLS CUI [1])
Hematocrit procedure
Item
hematocrit <25%;
boolean
C0018935 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine >4.0 mg/dl;
boolean
C0201976 (UMLS CUI [1])
thienopyridine
Item
thienopyridine use within 5 days of enrollment
boolean
C1120149 (UMLS CUI [1])
Glycoprotein GPIIb-IIIa | Patient need for Platelet Glycoprotein IIb/IIIA Inhibitors
Item
glycoprotein (gp) iib/iiia use within 8 hours of enrollment or any indication were the operator will require gp iib/iiia inhibitor use during the hospitalization.
boolean
C0016011 (UMLS CUI [1])
C0686904 (UMLS CUI [2,1])
C1373125 (UMLS CUI [2,2])